Response to Letter Regarding Article, “New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation”

Authors
Publication date
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1161%2Fcirculation...
      Last time updated on 23/04/2021